Announcement
28 Sep 2021
On 28 September 2021, the EIB provided financing worth EUR 15 million (USD 18 million) to support Dutch company Xeltis' research and development (R&D) investments related to cardiovascular therapy and implantable cardiovascular devices.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
28 Sep 2021
Revocation date:
No revocation date
Announced: 28 Sep 2021
State loan
In force
The EIB's EUR 15 million (approx. USD 18 million) loan to Xeltis signed on 28 September 2021 was backed by a guarantee from the Pan-European Guarantee Fund (EGF).
The EGF was created in April 2020 by ...
Sign in to see more
Announced: 28 Sep 2021
State loan
In force
On 28 September 2021, the European Investment Bank (EIB) and Dutch company Xeltis Bv signed an agreement worth EUR 15 million (approx. USD 18 million) to support the company's research and development...
Sign in to see more
Related State Acts
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70643
interventions
194
jurisdictions
Harmful Trade Policy Interventions: Medical Goods
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7346
interventions
152
jurisdictions